Relationship between serum b2-microglobulin levels and virological breakthrough in HBeAg-negative chronic hepatitis B patients, under long-term treatment schedules including lamivudine

doi:10.3748/wjg.v11.i13.1922

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2279)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

235

HTML

1775

Figures (1-1)

157

Tables (1-4)

112

Sum=2279

Apr 7, 2005 (publication date) through Jun 5, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Apr 7, 2005; 11(13): 1922-1928
Published online Apr 7, 2005. doi: 10.3748/wjg.v11.i13.1922

Relationship between serum b2-microglobulin levels and virological breakthrough in HBeAg-negative chronic hepatitis B patients, under long-term treatment schedules including lamivudine

Ioannis S. Elefsiniotis, Antonios Moulakakis, Konstantinos D. Pantazis, Irene Glynou, Ioannis Ketikoglou, Elena Vezali, Helen Kada, Epameinondas Tsianos

Ioannis S. Elefsiniotis, Antonios Moulakakis, Konstantinos D. Pantazis, Ioannis Ketikoglou, Elena Vezali, Department of Internal Medicine, Hippokration General Hospital, Athens, Greece

Irene Glynou, Helen Kada, Department of Microbiology, “Helena Venizelou” Hospital, Athens, Greece

Epameinondas Tsianos, Department of Hepatogastroenterology, University Hospital of Ioannina, Ioannina, Greece

Author contributions: All authors contributed equally to the work.

Correspondence to: Ioannis S. Elefsiniotis M.D., Carchidonos 9, A. Glyfada GR-16562, Greece. ielefs@acn.gr

Telephone: +3-210-9630312 Fax: +3-210-7787807

Received: October 19, 2004
Revised: October 20, 2004
Accepted: November 29, 2004
Published online: April 7, 2005

Core Tip